Medtecs International Corporation Limited (SGX: 546)
Singapore
· Delayed Price · Currency is SGD 0.134
0.00 (0.00%)
At close: Nov 22, 2024
Medtecs International Corporation Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 51.63 | 52.64 | 56.24 | 144.16 | 400.33 | 68.98 | Upgrade
|
| Revenue Growth (YoY) | 0.88% | -6.41% | -60.98% | -63.99% | 480.38% | 0.99% | Upgrade
|
| Cost of Revenue | 46.78 | 46.68 | 59.58 | 100.68 | 228.66 | 58.45 | Upgrade
|
| Gross Profit | 4.85 | 5.96 | -3.34 | 43.48 | 171.67 | 10.53 | Upgrade
|
| Selling, General & Admin | 29.02 | 30.95 | 29.73 | 27.47 | 35.46 | 7.5 | Upgrade
|
| Operating Expenses | 29.35 | 30.95 | 29.73 | 27.47 | 35.46 | 7.5 | Upgrade
|
| Operating Income | -24.5 | -24.99 | -33.07 | 16.01 | 136.21 | 3.04 | Upgrade
|
| Interest Expense | -0.76 | -0.74 | -0.82 | -0.85 | -1.49 | -2.29 | Upgrade
|
| Interest & Investment Income | 1.47 | 1.43 | 0.91 | 0.03 | 0.04 | 0.21 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.37 | -0.04 | 0.83 | 0.03 | -0.04 | 0.24 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.27 | 1.27 | 1.21 | 1.64 | 0.37 | 0.31 | Upgrade
|
| EBT Excluding Unusual Items | -22.15 | -23.07 | -30.94 | 16.86 | 135.09 | 1.51 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.35 | 0.35 | 0.17 | 0.06 | 0 | 0.01 | Upgrade
|
| Other Unusual Items | 0.21 | 0.21 | 0.04 | - | - | - | Upgrade
|
| Pretax Income | -21.6 | -22.52 | -30.65 | 16.92 | 135.09 | 1.52 | Upgrade
|
| Income Tax Expense | -0.17 | -0.03 | -1.39 | 0.41 | 3.37 | 0.35 | Upgrade
|
| Earnings From Continuing Operations | -21.43 | -22.49 | -29.26 | 16.51 | 131.72 | 1.17 | Upgrade
|
| Minority Interest in Earnings | 1.84 | 1.42 | 0.67 | 0.83 | -0.01 | -0 | Upgrade
|
| Net Income | -19.59 | -21.07 | -28.6 | 17.34 | 131.71 | 1.16 | Upgrade
|
| Net Income to Common | -19.59 | -21.07 | -28.6 | 17.34 | 131.71 | 1.16 | Upgrade
|
| Net Income Growth | - | - | - | -86.83% | 11234.85% | 27.13% | Upgrade
|
| Shares Outstanding (Basic) | 545 | 545 | 545 | 547 | 549 | 549 | Upgrade
|
| Shares Outstanding (Diluted) | 545 | 545 | 545 | 547 | 549 | 549 | Upgrade
|
| Shares Change (YoY) | - | -0.07% | -0.30% | -0.46% | - | - | Upgrade
|
| EPS (Basic) | -0.04 | -0.04 | -0.05 | 0.03 | 0.24 | 0.00 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.04 | -0.05 | 0.03 | 0.24 | 0.00 | Upgrade
|
| EPS Growth | - | - | - | -86.77% | 11266.95% | 27.12% | Upgrade
|
| Free Cash Flow | -5.81 | -12.08 | -16.26 | 13.73 | 92.94 | -0.2 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.03 | 0.03 | 0.17 | -0.00 | Upgrade
|
| Dividend Per Share | - | - | - | 0.006 | 0.050 | - | Upgrade
|
| Dividend Growth | - | - | - | -88.07% | - | - | Upgrade
|
| Gross Margin | 9.39% | 11.32% | -5.93% | 30.16% | 42.88% | 15.27% | Upgrade
|
| Operating Margin | -47.46% | -47.47% | -58.80% | 11.11% | 34.02% | 4.40% | Upgrade
|
| Profit Margin | -37.94% | -40.02% | -50.84% | 12.03% | 32.90% | 1.68% | Upgrade
|
| Free Cash Flow Margin | -11.26% | -22.94% | -28.91% | 9.52% | 23.22% | -0.29% | Upgrade
|
| EBITDA | -20.07 | -20.76 | -29.78 | 19.69 | 140.17 | 5.33 | Upgrade
|
| EBITDA Margin | -38.87% | -39.44% | -52.95% | 13.66% | 35.01% | 7.72% | Upgrade
|
| D&A For EBITDA | 4.44 | 4.23 | 3.29 | 3.68 | 3.96 | 2.29 | Upgrade
|
| EBIT | -24.5 | -24.99 | -33.07 | 16.01 | 136.21 | 3.04 | Upgrade
|
| EBIT Margin | -47.46% | -47.47% | -58.80% | 11.11% | 34.02% | 4.40% | Upgrade
|
| Effective Tax Rate | - | - | - | 2.41% | 2.50% | 23.14% | Upgrade
|
| Advertising Expenses | - | - | - | 1.44 | 0.05 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.